77 related articles for article (PubMed ID: 553036)
1. Evaluation of ten-year survival after operation for upper- and mid-thoracic esophageal cancer.
Kinoshita Y; Endo M; Nakayama K; Sato H; Sato H
Int Adv Surg Oncol; 1978; 1():173-200. PubMed ID: 553036
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of ten-year survival cases after operation for upper and mid-thoracic esophageal cancer.
Kinoshita Y; Endo M; Nakayama K; Sato H; Sato H
Int Surg; 1982; 67(2):153-61. PubMed ID: 7118473
[TBL] [Abstract][Full Text] [Related]
3. Carcinosarcoma of the esophagus: a twenty-case study.
Iyomasa S; Kato H; Tachimori Y; Watanabe H; Yamaguchi H; Itabashi M
Jpn J Clin Oncol; 1990 Mar; 20(1):99-106. PubMed ID: 2319703
[TBL] [Abstract][Full Text] [Related]
4. Lymph node dissection for thoracic esophageal carcinoma. Two- and 3-field lymph node dissection.
Kato H
Ann Chir Gynaecol; 1995; 84(2):193-9. PubMed ID: 7574380
[TBL] [Abstract][Full Text] [Related]
5. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
[TBL] [Abstract][Full Text] [Related]
7. Preoperative radiotherapy combined with resection of squamous cell carcinoma of the mid-thoracic oesophagus. Does a histopathological malignancy grading system assess actual survival?
Lewiński T; Morysiński T; Pietrow D; Sikora K
Eur J Surg Oncol; 1991 Dec; 17(6):571-4. PubMed ID: 1743305
[TBL] [Abstract][Full Text] [Related]
8. [Total esophagectomy and colon transplantation in treatment of upper neck esophageal carcinoma. Report of 16 cases].
Shi GN
Zhonghua Wai Ke Za Zhi; 1992 Apr; 30(4):214-5, 254. PubMed ID: 1473401
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between prognosis of esophageal squamous carcinoma and Langerhans cell].
Hou W; Liu K; Qu J
Zhonghua Wai Ke Za Zhi; 1996 Jul; 34(7):430-2. PubMed ID: 9590798
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of perioperative blood transfusions in resectable thoracic esophageal cancer.
Tachibana M; Tabara H; Kotoh T; Kinugasa S; Dhar DK; Hishikawa Y; Masunaga R; Kubota H; Nagasue N
Am J Gastroenterol; 1999 Mar; 94(3):757-65. PubMed ID: 10086663
[TBL] [Abstract][Full Text] [Related]
11. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
12. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic evaluation of lymph node metastasis in thoracic esophageal cancer--an analysis of 212 cases].
Chen JH; Wei GQ; Chen MY
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):441-3. PubMed ID: 7720501
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcome of esophageal cancer after distal gastrectomy: a prospective study.
Li HH; Zhang QZ; Xu L; Hu JW
Int J Surg; 2008 Apr; 6(2):129-35. PubMed ID: 18442806
[TBL] [Abstract][Full Text] [Related]
15. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
16. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach.
Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T
Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
19. Prognostic variables in thoracic esophageal squamous cell carcinoma.
Lin CS; Chang SC; Wei YH; Chou TY; Wu YC; Lin HC; Wang LS; Hsu WH
Ann Thorac Surg; 2009 Apr; 87(4):1056-65. PubMed ID: 19324127
[TBL] [Abstract][Full Text] [Related]
20. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
